Product Information

SUMATRIPTAN 20 MG NASAL SPRAY is a generic product labeled by Cipla USA Inc., priced at $16.8906 per EA under NDC 69097064448. Its NADAC has been published 273 times since Jun 2, 2021.

FDA first approved this application on Feb 22, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SUMATRIPTAN 20 MG NASAL SPRAY

Sumatriptan
$16.8906per EA

Strength

20 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097064448

Classification

Generic

Dosage Form

SPRAY

Route

NASAL

Effective Date

8/19/2026

Active Ingredients

SUMATRIPTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA214209

FDA Approved

2/22/2021

TE Code

AB

On Market Since

2/22/2021

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for SUMATRIPTAN 20 MG NASAL SPRAY has been published 273 times since Jun 2, 2021, and over the history we have for it it has declined 55.7%. The table below summarizes its recorded NADAC range and movement.

Current price$16.8906 per EA
All-time high$38.5022 (Aug 11, 2021)
All-time low$13.8657 (Nov 20, 2024)
52-week high$18.0509
52-week low$15.8842
Median price$19.2609
Average price$21.0311
Largest weekly change-38.3% (Nov 20, 2024)
Weeks tracked273
Tracking sinceJun 2, 2021

Price History

1W

+1.1%

1M

+1.1%

3M

+5.2%

6M

+3.3%

1Y

-6.4%

3Y

-11.3%

5Y

-55.3%

All

-55.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of SUMATRIPTAN 20 MG NASAL SPRAY?

The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN 20 MG NASAL SPRAY, manufactured by Cipla USA Inc., is $16.8906 per EA (NDC 69097064448), effective Aug 19, 2026.

How has the price of SUMATRIPTAN 20 MG NASAL SPRAY changed over time?

Over the history we have for it, the NADAC for SUMATRIPTAN 20 MG NASAL SPRAY has declined 55.7%. It has been tracked across 273 weekly CMS publications since Jun 2, 2021.

What are the highest and lowest recorded NADAC prices for SUMATRIPTAN 20 MG NASAL SPRAY?

Since Jun 2, 2021, the NADAC for SUMATRIPTAN 20 MG NASAL SPRAY has ranged from a low of $13.8657 (Nov 20, 2024) to a high of $38.5022 (Aug 11, 2021), with a median of $19.2609 per EA.

Are there cheaper alternatives to SUMATRIPTAN 20 MG NASAL SPRAY?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SUMATRIPTAN 20 MG NASAL SPRAY in a comparable dosage form, but none are currently priced below it.

Who manufactures SUMATRIPTAN 20 MG NASAL SPRAY?

SUMATRIPTAN 20 MG NASAL SPRAY (NDC 69097064448) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.